Strides Pharma Science Ltd (IN:STAR)
:STAR
Total Valuation
Strides Pharma Science Ltd has a market cap or net worth of ₹89.14B. The enterprise value is ₹105.90B.
Market Cap₹89.14B
Enterprise Value₹105.90B
Share Statistics
Strides Pharma Science Ltd has 92,172,714 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,172,714
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Strides Pharma Science Ltd’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 9.24%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.24%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee14.60M
Profits Per Employee1.32M
Employee Count3,065
Asset Turnover0.74
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Strides Pharma Science Ltd is 10.3. Strides Pharma Science Ltd’s PEG ratio is -0.03.
PE Ratio10.3
PS Ratio1.37
PB Ratio2.40
Price to Fair Value2.40
Price to FCF13.88
Price to Operating Cash Flow23.41
PEG Ratio-0.03
Income Statement
In the last 12 months, Strides Pharma Science Ltd had revenue of 44.75B and earned 4.05B in profits. Earnings per share was 44.05.
Revenue44.75B
Gross Profit11.83B
Operating Income5.18B
Pretax Income4.87B
Net Income4.05B
EBITDA7.10B
Earnings Per Share (EPS)44.05
Cash Flow
In the last 12 months, operating cash flow was 3.91B and capital expenditures -1.49B, giving a free cash flow of 2.42B billion.
Operating Cash Flow3.91B
Free Cash Flow2.42B
Free Cash Flow per Share26.29
Dividends & Yields
Strides Pharma Science Ltd pays an annual dividend of ₹4, resulting in a dividend yield of 0.41%
Dividend Per Share₹4
Dividend Yield0.41%
Payout Ratio9.15%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change66.33%
50-Day Moving Average882.02
200-Day Moving Average881.28
Relative Strength Index (RSI)63.58
Average Volume (3m)12.54K
Important Dates
Strides Pharma Science Ltd upcoming earnings date is May 21, 2026, TBA (Confirmed).
Last Earnings DateJan 30, 2026
Next Earnings DateMay 21, 2026
Ex-Dividend Date―
Financial Position
Strides Pharma Science Ltd as a current ratio of 1.20, with Debt / Equity ratio of 66.91%
Current Ratio1.20
Quick Ratio0.70
Debt to Market Cap0.29
Net Debt to EBITDA2.46
Interest Coverage Ratio2.08
Taxes
In the past 12 months, Strides Pharma Science Ltd has paid 775.16M in taxes.
Income Tax775.16M
Effective Tax Rate0.16
Enterprise Valuation
Strides Pharma Science Ltd EV to EBITDA ratio is 11.10, with an EV/FCF ratio of 17.83.
EV to Sales1.76
EV to EBITDA11.10
EV to Free Cash Flow17.83
EV to Operating Cash Flow11.51
Balance Sheet
Strides Pharma Science Ltd has ₹2.27B in cash and marketable securities with ₹18.44B in debt, giving a net cash position of -₹16.16B billion.
Cash & Marketable Securities₹2.27B
Total Debt₹18.44B
Net Cash-₹16.16B
Net Cash Per Share-₹175.37
Tangible Book Value Per Share₹159.97
Margins
Gross margin is 36.00%, with operating margin of 11.58%, and net profit margin of 9.06%.
Gross Margin36.00%
Operating Margin11.58%
Pretax Margin10.88%
Net Profit Margin9.06%
EBITDA Margin15.86%
EBIT Margin11.58%
Analyst Forecast
The average price target for Strides Pharma Science Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.22%
EPS Growth Forecast123.83%